Understanding and treating cancer metastasis remains a major challenge in oncology. Traditional in vitro methods often fall short in capturing the complex phenotypes associated with metastatic progression. Scalable phenotypic assays that can sensitively detect anti-metastatic effects are needed to drive therapeutic discovery forward.
In this application note, you will explore:
- How CytoTronics’ electrical imaging platform captures real-time changes in cell attachment, motility, and other key indicators of metastatic potential
- Multi-parametric data from triple-negative breast cancer cells characterizing response to Dexamethasone, a known anti-metastatic agent
Measuring dexamethasone response in triple-negative breast cancer cells.
